Intervention Review

Aripiprazole for autism spectrum disorders (ASD)

  1. Heidi Ching1,
  2. Tamara Pringsheim2,*

Editorial Group: Cochrane Developmental, Psychosocial and Learning Problems Group

Published Online: 16 MAY 2012

Assessed as up-to-date: 4 NOV 2011

DOI: 10.1002/14651858.CD009043.pub2


How to Cite

Ching H, Pringsheim T. Aripiprazole for autism spectrum disorders (ASD). Cochrane Database of Systematic Reviews 2012, Issue 5. Art. No.: CD009043. DOI: 10.1002/14651858.CD009043.pub2.

Author Information

  1. 1

    Albany Medical College, Albany, NY, USA

  2. 2

    University of Calgary, Clinical Assistant Professor, Department of Clinical Neurosciences and Pediatrics, Calgary, Alberta, Canada

*Tamara Pringsheim, Clinical Assistant Professor, Department of Clinical Neurosciences and Pediatrics, University of Calgary, Alberta Children's Hospital, C4-431, 2888 Shaganappi Trail NW, Calgary, Alberta, T3B 6A8, Canada. tmprings@ucalgary.ca.

Publication History

  1. Publication Status: New
  2. Published Online: 16 MAY 2012

SEARCH

  1. Current Version

    Aripiprazole for autism spectrum disorders (ASD)

    Heidi Ching and Tamara Pringsheim

    Article first published online: 16 MAY 2012 | DOI: 10.1002/14651858.CD009043.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Aripiprazole for Autism Spectrum Disorders (ASD)

    Heidi Ching and Tamara Pringsheim

    Article first published online: 16 MAR 2011 | DOI: 10.1002/14651858.CD009043